Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 16 de 16
Filtrar
1.
An. bras. dermatol ; An. bras. dermatol;93(5): 749-751, Sept.-Oct. 2018. graf
Artigo em Inglês | LILACS | ID: biblio-949958

RESUMO

Abstract: We present a different and rare manifestation of Darier's disease, namely linear Darier's disease. Only a few cases have been described in the literature. The case report is a male patient, 60 years old, presenting brown to red papules and plaques with hyperkeratosis distributed on the abdomen, following Blaschko's lines, with 6 years' evolution. It was a difficult diagnosis until the dermatological workup and biopsy.


Assuntos
Humanos , Masculino , Pessoa de Meia-Idade , Doença de Darier/diagnóstico , Fotografação , Acitretina/administração & dosagem , Ceratolíticos/administração & dosagem , Doença de Darier/patologia , Doença de Darier/tratamento farmacológico , Ilustração Médica
2.
Rev. Assoc. Med. Bras. (1992, Impr.) ; Rev. Assoc. Med. Bras. (1992, Impr.);64(2): 127-132, Feb. 2018. tab, graf
Artigo em Inglês | LILACS | ID: biblio-896439

RESUMO

Summary Introduction: The association of osmidrosis and hyperhidrosis often causes emotional and social problems that may impair the patients' quality of life. The purpose of our study was to analyze the therapeutic results of oxybutynin and topical agents in 89 patients with both osmidrosis and hyperhidrosis. Method: We conducted an observational study at two specialized centers of hyperhidrosis between April 2007 and August 2013. Eighty-nine (89) patients with both osmidrosis and hyperhidrosis were treated with oxybutynin and topical agents. Patients were evaluated before treatment and at 3 and 6 weeks after treatment started, by using the Quality of Life Questionnaire and the Sweating Evolution Scale. Results: Before treatment, 98% of the patients presented with poor or very poor quality of life. After six weeks of treatment, 70% stated their quality of life as being slightly better or much better (p<0.001) and nearly 70% of the patients experienced a moderate or great improvement in sweating and malodor. Improvement in osmidrosis was significantly greater when the axillary region was the first most disturbing site of hyperhidrosis. Conclusion: There was a significant improvement in quality of life and a reduction in sweating and malodor after six weeks of treatment with topical agents and oxybutynin in patients with both hyperhidrosis and osmidrosis. Therefore, clinical treatment should be considered before invasive techniques.


Resumo Introdução: A associação entre osmidrose e hiper-hidrose com frequência causa problemas emocionais e sociais que podem deteriorar a qualidade de vida dos pacientes. O objetivo deste estudo foi analisar os resultados terapêuticos do uso de oxibutinina associada a agentes tópicos em 89 pacientes com osmidrose e hiper-hidrose. Método: Nós conduzimos um estudo observacional em dois centros especializados em hiper-hidrose entre abril de 2007 e agosto de 2013. Oitenta e nove (89) pacientes com osmidrose associada a hiper-hidrose foram tratados com oxibutinina e agentes tópicos. Os pacientes foram avaliados antes do tratamento e após 3 e 6 semanas do início do tratamento, por meio do Questionário de Qualidade de Vida e da Escala de Evolução da Sudorese. Resultados: Antes do tratamento, 98% dos pacientes apresentavam qualidade de vida ruim ou muito ruim. Após seis semanas de tratamento, 70% classificou sua qualidade de vida como sendo pouco ou muito melhor (p<0.001) e aproximadamente 70% dos pacientes relataram melhora moderada ou grande de sudorese e odor. Houve melhora significativamente maior da osmidrose quando a região axilar era o sítio em que a hiper-hidrose mais incomodava. Conclusão: Houve melhora significativa da qualidade de vida e uma redução da sudorese e do odor após seis semanas de tratamento com agentes tópicos e oxibutinina em pacientes com hiper-hidrose associada a osmidrose. Dessa maneira, a terapia clínica deve ser considerada antes de técnicas invasivas.


Assuntos
Humanos , Masculino , Feminino , Pré-Escolar , Criança , Adolescente , Adulto , Adulto Jovem , Antagonistas Muscarínicos/uso terapêutico , Hiperidrose/tratamento farmacológico , Ácidos Mandélicos/uso terapêutico , Odorantes , Qualidade de Vida/psicologia , Sabões/administração & dosagem , Sudorese , Clindamicina/administração & dosagem , Inquéritos e Questionários , Estudos Retrospectivos , Administração Tópica , Resultado do Tratamento , Quimioterapia Combinada , Ceratolíticos/administração & dosagem , Pessoa de Meia-Idade , Antibacterianos/administração & dosagem , Antifúngicos/administração & dosagem
3.
An. bras. dermatol ; An. bras. dermatol;92(3): 363-366, May-June 2017.
Artigo em Inglês | LILACS | ID: biblio-886957

RESUMO

Abstract The tretinoin peel, also known as retinoic acid peel, is a superficial peeling often performed in dermatological clinics in Brazil. The first study on this was published in 2001, by Cuce et al., as a treatment option for melasma. Since then, other studies have reported its applicability with reasonable methodology, although without a consistent scientific background and consensus. Topical tretinoin is used for the treatment of various dermatoses such as acne, melasma, scars, skin aging and non-melanoma skin cancer. The identification of retinoids cellular receptors was reported in 1987, but a direct cause-effect relation has not been established. This article reviews studies evaluating the use of topical tretinoin as agent for superficial chemical peel. Most of them have shown benefits in the treatment of melasma and skin aging. A better quality methodology in the study design, considering indication and intervention is indispensable regarding concentration, vehicle and treatment regimen (interval and number of applications). Additionally, more controlled and randomized studies comparing the treatment with tretinoin cream versus its use as a peeling agent, mainly for melasma and photoaging, are necessary.


Assuntos
Humanos , Dermatopatias/tratamento farmacológico , Tretinoína/administração & dosagem , Envelhecimento da Pele/efeitos dos fármacos , Abrasão Química/métodos , Ceratolíticos/administração & dosagem
4.
An. bras. dermatol ; An. bras. dermatol;88(6): 900-905, Nov-Dec/2013. tab, graf
Artigo em Inglês | LILACS | ID: lil-699000

RESUMO

BACKGROUND: Peeling is a procedure which aims to accelerate the process of skin exfoliation. OBJECTIVES: Development of formulations containing lactic acid at 85% or glycolic acid at 70% and the evaluation of these formulations on clinical efficacy in reduction of fine wrinkles. METHODS: Preliminary stability tests were carried out and an in vivo study was performed with three groups with 9 representatives each. One was the control group, which used only sunscreen; another one used lactic acid+sunscreen, and the last group used acid glycolic+sunscreen. Clinical efficacy was assessed with a CCD color microscope, through the digitization of images before and after treatment. The applications were carried out by a dermatologist, once a mont h every 30 days, during 3 months. The area with wrinkles was calculated by planimetry point counting, in accordance with Mandarin-de-Lacerda. RESULTS: The formulations were stable in the visual and Ph evaluation. There was no improvement in the control group; for lactic acid, there was significant improvement after the second peeling application on the outer lateral area of the right eye and after the third application on the outer lateral area of the left eye. For the glycolic acid group, there was significant improvement in the outer lateral area of the left eye after the first application, and of the right eye region, after three applications. The formulations used must be kept under refrigeration and should be manipulated every 30 days. CONCLUSIONS: Both peelings were effective in reducing fine wrinkles of the outer lateral eye area after three applications (p≤0.05%). It was observed that peeling efficacy in the external-lateral region of one eye might be different compared with that in skin of the external-lateral region of the other eye, relative to the speed of skin improvement. .


FUNDAMENTOS: Peeling visa a acelerar o processo de esfoliação da pele. OBJETIVOS: Desenvolver formulações contendo ácido láctico a 85% ou ácido glicólico a 70% e avaliar sua eficácia clínica na redução de rugas finas. MÉTODOS: Testes preliminares foram efetuados e estudo in vivo foi realizado em três grupos com nove representantes cada, separados de forma randomizada. Um grupo foi controle, utilizando apenas fotoprotetor; outro utilizou ácido láctico e fotoprotetor; o último usou ácido glicólico e fotoprotetor. Para eficácia clínica, empregou-se microscópio CCD color, digitalizando-se as imagens do pré e do pós-tratamento. As aplicações foram realizadas por médica dermatologista uma vez por mês, a cada 30 dias, durante três meses. A área com traços de ruga foi calculada pela planimetria por contagem de pontos. RESULTADOS: As formulações foram estáveis na avaliação visual e de pH. Não houve melhora no grupo controle; para o grupo do ácido láctico, houve melhora significativa após a segunda aplicação do peeling na região lateral externa do olho direito e após a terceira aplicação na região lateral externa olho esquerdo. Para o grupo do ácido glicólico, houve melhora significativa na região lateral externa olho esquerdo após a primeira aplicação e, depois de três aplicações, na região lateral externa do olho direito. As formulações magistrais empregadas no estudo devem ser mantidas sob refrigeração e manipuladas a cada 30 dias. CONCLUSÕES: Tanto o peeling de ácido láctico quanto o de ácido glicólico foram eficazes na diminuição de rugas finas da região lateral externa dos olhos após ...


Assuntos
Adulto , Feminino , Humanos , Pessoa de Meia-Idade , Abrasão Química/métodos , Glicolatos/administração & dosagem , Ceratolíticos/administração & dosagem , Ácido Láctico/administração & dosagem , Envelhecimento da Pele/efeitos dos fármacos , Administração Tópica , Análise de Variância , Olho , Reprodutibilidade dos Testes , Pele/efeitos dos fármacos , Fatores de Tempo , Resultado do Tratamento
5.
Indian J Dermatol Venereol Leprol ; 2013 Nov-Dec; 79(6): 759-771
Artigo em Inglês | IMSEAR | ID: sea-154675

RESUMO

Acitretin, a synthetic retinoid has gradually replaced etretinate in today’s dermatologic practice because of its more favorable pharmacokinetics. Acitretin over the past 20 years has proven useful in a number of diffi cult-to-treat hyperkeratotic and infl ammatory dermatoses and nonmelanoma skin cancers. It is effective both as monotherapy and in combination with other drugs for hyperkeratotic disorders. It is considered to be an established second line treatment for psoriasis and exerts its effect mainly due to its antikeratinizing, antiinfl ammatory, and antiproliferative effect. Its antineoplastic properties make it a useful agent for cancer prophylaxis. Evidence-based effi cacy, side-effect profi le, and approach to the use of acitretin would be discussed in this review. In addition to its approved uses, the various off label uses will also be highlighted in this section. Since its use is limited by its teratogenic potential and other adverse effects, including mucocutaneous effects and hepatotoxicity, this review would summarize the contraindications and precautions to be exercised before prescribing acitretin.


Assuntos
Acitretina/administração & dosagem , Acitretina/farmacocinética , Animais , Antineoplásicos/administração & dosagem , Antineoplásicos/farmacocinética , Diferenciação Celular/efeitos dos fármacos , Diferenciação Celular/fisiologia , Dermatologia/métodos , Dermatologia/tendências , Humanos , Ceratolíticos/administração & dosagem , Ceratolíticos/farmacocinética , Lesões Pré-Cancerosas/patologia , Lesões Pré-Cancerosas/prevenção & controle , Absorção Cutânea/efeitos dos fármacos , Absorção Cutânea/fisiologia , Dermatopatias/tratamento farmacológico , Dermatopatias/patologia
6.
Gac. méd. Caracas ; 121(3): 234-240, jul.-sept. 2013. tab
Artigo em Espanhol | LILACS | ID: lil-731327

RESUMO

La isotretinoína es un retinoide empleado en el tratamiento del acné. El objetivo de este estudio fue determinar colesterol, triglicéridos, transaminasa glutámico oxalacética, transaminasa glutámico pirúvica y fosfatasa alcalina, pretratamiento, trimestralmente durante el tratamiento y postratamiento en pacientes tratados con isotretinoína oral procedentes de consultas dermatológicas del Estado Carabobo. La edad Promedio de la muestra estudiada fue (19,4 ± 4,7 años), los valores de colesterol mostraron variación estadísticamente significativa para el primer trimestre (P=0,044), Los triglicéridos se incrementaron en el segundo trimestre (P=0,036) para ambos géneros, mientras que para el tercer trimestre solo el género masculino experimentó incremento. Transaminasa glutámico oxalacético en el primer trimestre se incrementó en el género femenino, sin embargo, no fue estadísticamente significativo. En los demás trimetres los valores de las enzimas hepáticas no superaron los valores de referencia. No se evidencian diferencias estadísticamente significativas entre los niveles del pretratamiento y postratamiento. Es recomendable monitorear los lípidos séricos y transaminasas durante el primer trimestre de tratamiento aunque los cambios observados fueron discretos en la mayoría de los pacientes


Isotretinoin is a retinoid used to treat acne. The aim of this sindy was to determine cholesterol, triglyceride, seric glutami oxalacetic transaminase, seric glutami pyruvic transaminase and alkaline phosphatase pretreatment, quarterly during treatment and post-treatment in patients treated with oral isotretinoin dermatological consultations from Carabobo State. The overage age of the sample was (19.4 ± 4.7 years), cholesterol values showed statistically significant variation in the first quarter (P=0.044). Triglycerides increased in the second quarter (P=0.036) for both genders, while for the third quarter only increase in male. Seric glutami oxalacetic transaminase in the first quarter increased in females, but was not statistically significant. In other quarters the liver enzyme values did not exceed reference values. No statistically significant differences are evident between the levels of pretreatment and postreatment. It is advisable to monitor serum lipids and transaminases during the first quarter of treatment although the observed changes were discrete in most patients


Assuntos
Humanos , Masculino , Adolescente , Feminino , Acne Vulgar/diagnóstico , Acne Vulgar/terapia , Colesterol/sangue , Fármacos Dermatológicos/administração & dosagem , Isotretinoína/uso terapêutico , Retinoides/efeitos adversos , Triglicerídeos/sangue , Aspartato Aminotransferases/análise , Ceratolíticos/administração & dosagem , Glândulas Sebáceas , Transaminases/análise
7.
Biomédica (Bogotá) ; Biomédica (Bogotá);32(1): 125-133, ene.-mar. 2012. ilus, graf, tab
Artigo em Espanhol | LILACS | ID: lil-639818

RESUMO

Introducción. Actualmente, la resistencia a los antimicrobianos de las cepas bacterianas involucradas en el desarrollo del acné es una realidad y se hace necesario buscar alternativas terapéuticas para su tratamiento. Objetivos. Diseñar fórmulas en gel a base de aceites esenciales y ácido acético, y evaluar su efectividad en pacientes voluntarios afectados por acné. Materiales y métodos. Se trata de un estudio experimental simple enmascarado de tres fórmulas en gel sobre cuatro grupos de siete pacientes. Los tratamientos antibacterianos (aceites esenciales), queratolíticos y mixtos (ácido acético), se aplicaron diariamente por espacio de ocho semanas. Se hicieron controles semanales para evaluar la evolución de los pacientes. Resultados. Todos los grupos reportaron mejoría (desaparición de las lesiones) de la condición del acné, la cual osciló entre 43 y 75 %, con leves efectos secundarios transitorios relacionados con la aplicación de los tratamientos utilizados. Conclusiones. Las fórmulas estudiadas mostraron ser estables química y físicamente durante la aplicación de los tratamientos, lo cual se demostró mediante análisis de cromatografía de gases, en la cual no se evidenció ningún cambio en los perfiles de composición de los aceites esenciales ni en el del ácido acético. Los resultados se catalogaron entre buenos y excelentes, en particular, el del ácido acético, que logró mejorías superiores al 75 %, dada su actividad mixta antiséptica y queratolítica. Los efectos secundarios (ardor y enrojecimiento) desaparecieron a los pocos minutos de realizada la aplicación y no impidieron el cumplimiento de los tratamientos.


Introduction. Currently, the antimicrobial resistance has developed in bacterial strains involved in the development of acne. Therefore, alternatives to antibiotic treatment have become necessary. Objectives. Gel formulations were designed based on essential oils and acetic acid, and their effectiveness was evaluated in patients affected by acne. Materials and methods. Masked simple experimental study of three gel formulations on 28 volunteer patients, separated in four groups of seven patients. Treatments were applied daily for eight weeks and consisted of (1) antibacterial (essential oils), (2) keratolytic medication (3) essential oils mixed with acetic acetic, and (4) kerolytic medication with acetic acid. Weekly checks were conducted to evaluate patient improvement. Results. All groups reported an improvement of the acne condition, which ranged between 43% and 75% clearance of lesions. Evidence of treatment disappeared within minutes, showing little discomfort or side effects after application. Conclusions. The essential oil formulations were chemically and physically stable during application of treatments. This was demonstrated by gas chromatography, where no evidence no change neither the composition profiles of essential oils nor in acetic acid. The results were ranked good to excellent, particularly for the acetic acid mixture, which achieved improvements of 75%. This appeared to be a result of their joint antiseptic and keratolytic activity. Side effects (burning and redness) disappeared within a few minutes of completing the application, therefore, did not interfere with adherence to treatment.


Assuntos
Adolescente , Adulto , Feminino , Humanos , Masculino , Adulto Jovem , Acne Vulgar/tratamento farmacológico , Citrus sinensis , Fármacos Dermatológicos/uso terapêutico , Ocimum basilicum , Óleos Voláteis/uso terapêutico , Fitoterapia , Óleos de Plantas/uso terapêutico , Administração Cutânea , Ácido Acético/administração & dosagem , Ácido Acético/uso terapêutico , Antibacterianos/administração & dosagem , Antibacterianos/uso terapêutico , Química Farmacêutica , Cromatografia Gasosa , Combinação de Medicamentos , Fármacos Dermatológicos/química , Géis , Concentração de Íons de Hidrogênio , Ceratolíticos/administração & dosagem , Ceratolíticos/uso terapêutico , Óleos Voláteis/administração & dosagem , Óleos de Plantas/administração & dosagem , Propionibacterium acnes/efeitos dos fármacos , Método Simples-Cego , Staphylococcus epidermidis/efeitos dos fármacos
9.
Artigo em Inglês | WPRIM | ID: wpr-148951

RESUMO

Minoxidil induces hair growth in male pattern baldness and prolongs the anagen phase. All-trans retinoic acid (ATRA) has been reported to act synergistically with minoxidil in vivo: they can enhance more dense hair regrowth than either compound alone. We evaluated the effect of minoxidil combined with ATRA on hair growth in vitro. The effect of co-treatment of minoxidil and ATRA on hair growth was studied in hair follicle organ culture. In cultured human dermal papilla cells (DPCs) and normal human epidermal keratinocytes, the expressions of Erk, Akt, Bcl-2, Bax, P53 and P21 were evaluated by immunoblot analysis. Minoxidil plus ATRA additively promoted hair growth in vitro, compared with minoxidil alone. In addition, minoxidil plus ATRA elevated phosphorylated Erk, phosphorylated Akt and the ratio of Bcl-2/Bax, but decreased the expressions of P53 and P21 more effectively than by minoxidil alone. Our results suggest that minoxidil plus ATRA would additively enhance hair growth by mediating dual functions: 1) the prolongation of cell survival by activating the Erk and Akt signaling pathways, and 2) the prevention of apoptosis of DPCs and epithelial cells by increasing the ratio of Bcl-2/Bax and downregulating the expressions of P53 and P21.


Assuntos
Humanos , Tretinoína/administração & dosagem , Minoxidil/administração & dosagem , Ceratolíticos/administração & dosagem , Cabelo/citologia , Combinação de Medicamentos , Relação Dose-Resposta a Droga , Células Cultivadas , Proliferação de Células/efeitos dos fármacos
11.
Indian J Dermatol Venereol Leprol ; 2006 Jan-Feb; 72(1): 43-6
Artigo em Inglês | IMSEAR | ID: sea-52041

RESUMO

In 1937, Siemens described a Dutch family with superficial blistering, flexural hyperkeratosis, and characteristic mauserung appearance. Since then, less than 20 kindreds with this condition have been described in the English dermatologic literature. A 14-year-old boy presented with history of recurrent blistering and peeling of skin since the age of 1 month, predominantly seen over limbs and trunk, often associated with secondary infection. His mother also had similar symptoms from childhood. On examination, the child had typical mauserung peeling of the skin and dirty gray hyperkeratosis in a rippled pattern over flexures. Skin biopsy from the boy showed intracorneal blistering with epidermolytic hyperkeratosis in the upper spinous layers. The typical history and clinical features along with characteristic histological findings confirmed our diagnosis of ichthyosis bullosa of Siemens. It must be differentiated from other conditions with epidermolytic hyperkeratosis and skin peeling, such as bullous ichthyosiform erythroderma of Brocq and peeling skin syndrome. Our patient responded well to 0.05% topical tazarotene gel over four weeks.


Assuntos
Administração Tópica , Adolescente , Adulto , Feminino , Géis , Humanos , Hiperceratose Epidermolítica/tratamento farmacológico , Ceratolíticos/administração & dosagem , Masculino , Ácidos Nicotínicos/administração & dosagem , Dermatopatias Vesiculobolhosas/tratamento farmacológico , Resultado do Tratamento
12.
Asian Pac J Allergy Immunol ; 2005 Jun-Sep; 23(2-3): 107-13
Artigo em Inglês | IMSEAR | ID: sea-36897

RESUMO

Vascular replacement in vital organs is sometimes necessary for human life for example because of atherosclerosis. Blood vessel tissue engineering is applied for autologous transplantations to avoid graft rejections. Stem cells are used for blood vessel tissue engineering because they are the origin of smooth muscle cells, endothelial cells and fibroblasts. This paper shows that bone marrow stromal cells (BMSCs) can be induced to differentiate into the early stage of smooth muscle cells by using 0.01 microM retinoic acid. The differentiation of BMSCs to smooth muscle cells was detected by the expression of smooth muscle alpha actin (SM alpha-actin), the earliest smooth muscle cell marker. The SM alpha-actin marker expression was demonstrated using indirect immunofluorescence technique and Western blot analysis. The induction of BMSC to form early stages of smooth muscle cells in this study is appropriate for blood vessel tissue engineering because the early stage smooth muscle cells may be stimulated to develop vascular walls with endothelial cells using a co-culture system.


Assuntos
Actinas/efeitos dos fármacos , Western Blotting , Células da Medula Óssea/efeitos dos fármacos , Contagem de Células , Diferenciação Celular/efeitos dos fármacos , Divisão Celular/efeitos dos fármacos , Relação Dose-Resposta a Droga , Imunofluorescência , Humanos , Ceratolíticos/administração & dosagem , Miócitos de Músculo Liso/efeitos dos fármacos , Células Estromais/efeitos dos fármacos , Fator de Crescimento Transformador beta/farmacologia , Fator de Crescimento Transformador beta1 , Tretinoína/administração & dosagem
13.
Indian J Dermatol Venereol Leprol ; 2005 Mar-Apr; 71(2): 87-90
Artigo em Inglês | IMSEAR | ID: sea-52127

RESUMO

BACKGROUND: Chemical peeling is a skin-wounding procedure that may have some potentially undesirable side-effects. AIMS: The present study is directed towards safety concerns associated with superficial chemical peeling with salicylic acid in various facial dermatoses. METHODS: The study was a non-comparative and a prospective one. Two hundred and sixty-eight patients of either sex, aged between 10 to 60 years, undergoing superficial chemical peeling for various facial dermatoses (melasma, acne vulgaris, freckles, post-inflammatory scars/pigmentation, actinic keratoses, plane facial warts, etc.) were included in the study. Eight weekly peeling sessions were carried out in each patient. Tolerance to the procedure and any undesirable effects noted during these sessions were recorded. RESULTS: Almost all the patients tolerated the procedure well. Mild discomfort, burning, irritation and erythema were quite common but the incidence of major side-effects was very low and these too, were easily manageable. There was no significant difference in the incidence of side-effects between facial dermatoses (melasma, acne and other pigmentary disorders). CONCLUSION: Chemical peeling with salicylic acid is a well tolerated and safe treatment modality in many superficial facial dermatoses.


Assuntos
Adolescente , Adulto , Abrasão Química , Criança , Dermatoses Faciais/terapia , Feminino , Humanos , Ceratolíticos/administração & dosagem , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Ácido Salicílico/administração & dosagem
14.
Indian J Pediatr ; 1998 Mar-Apr; 65(2): 320-3
Artigo em Inglês | IMSEAR | ID: sea-81166

RESUMO

Harlequin fetus is the severe form of congenital ichthyosis. There are very few reports of babies with this condition surviving the first few weeks of life. We treated two siblings who lived for 22 months and six weeks respectively. We started treatment with oral etretinate every early in their lives and achieved good improvement in the skin condition of these babies.


Assuntos
Administração Oral , Etretinato/administração & dosagem , Seguimentos , Humanos , Ictiose Lamelar/tratamento farmacológico , Lactente , Recém-Nascido , Ceratolíticos/administração & dosagem
15.
Dermatol. rev. mex ; 41(5): 192-3, sept.-oct. 1997. ilus
Artigo em Espanhol | LILACS | ID: lil-214278

RESUMO

Se comunica el caso de una mujer de 34 años de edad con pigmentación macular eruptiva idiopática, enfermedad poco reportada y frecuentemente diagnosticada como otro tipo de melanosis, de presentación común en la infancia


Assuntos
Humanos , Feminino , Adulto , Ceratolíticos/uso terapêutico , Ceratolíticos/administração & dosagem , Eritema , Melanose , Pigmentação da Pele , Protetores Solares , Protetores Solares/uso terapêutico
16.
Dermatol. rev. mex ; 39(2): 85-8, mar.-abr. 1995. tab
Artigo em Espanhol | LILACS | ID: lil-151927

RESUMO

Se presenta una revisión de un total de 11 estudios. Dos estudios realizados en México y 9 en diferentes países. Se incluyeron 429 pacientes con diagnóstico de onicomicosis con confirmación clínica y micológica. El tratamiento consistió en dos pasos: 1) Tratamiento inicial con aplicaciones en la uña infectada de bifonazol-urea cada 24 horas bajo vendaje oclusivo hasta el desprendimiento atraumático de la uña; 2) Tratamiento subsecuente del lecho ungueal con bifonazol crema (Solución o gel) 1 vez al día, durante 4 a 6 semanas. El tiempo del desprendimiento atraumático de la uña fue de 4 a 45 días. El porcentaje de curación micológica fue de 81.44 por ciento en los 9 estudios y en los de México de 79.7 por ciento. La combinación de bifonazol al 1 por ciento más urea al 40 por ciento por ser un medicamento antimicótico y queratolítico es una excelente alternativa terapeútica en los siguientes casos: en pacientes que no excedan de cuatro uñas parasitadas, en pacientes que no puedan ser sometidas a largos tratamientos con antimicóticos sistémicos, anicolisis por Candida y onicomicosis infantil


Assuntos
Criança , Adulto , Humanos , Masculino , Feminino , Antifúngicos/administração & dosagem , Antifúngicos/uso terapêutico , Ceratolíticos/administração & dosagem , Ceratolíticos/uso terapêutico , Candida/patogenicidade , Dermatomicoses/tratamento farmacológico , Dermatomicoses/etiologia , Combinação de Medicamentos , Onicomicose/diagnóstico , Onicomicose/fisiopatologia , Onicomicose/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA